Home › Funds › Vanguard Group › BCLI
Vanguard Group position in BCLI
BRAINSTORM CELL THERAPEUTICS
Latest position (Q2 2025)27.72K sh
Reported value held$31.05K
Portfolio Weight0.00%
First reportedQ1 2021
Last changeHold
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2021 | 1.33M | $5.10M | New |
| Q2 2021 | 1.41M | $5.37M | Add |
| Q3 2021 | 1.43M | $4.73M | Add |
| Q4 2021 | 1.43M | $5.72M | Hold |
| Q1 2022 | 1.42M | $4.78M | Reduce |
| Q2 2022 | 1.43M | $3.94M | Hold |
| Q3 2022 | 1.43M | $6.31M | Hold |
| Q4 2022 | 1.43M | $2.34M | Hold |
| Q1 2023 | 1.43M | $4.71M | Hold |
| Q2 2023 | 1.42M | $2.93M | Hold |
| Q3 2023 | 1.42M | $284.80K | Hold |
| Q4 2023 | 1.42M | $388.56K | Hold |
| Q1 2024 | 1.40M | $791.14K | Reduce |
| Q2 2024 | 1.51M | $511.35K | Add |
| Q3 2024 | 1.51M | $347.45K | Hold |
| Q4 2024 | 78.44K | $178.06K | Reduce |
| Q1 2025 | 27.72K | $34.93K | Reduce |
| Q2 2025 | 27.72K | $31.05K | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.